메뉴 건너뛰기
Journal of Gastroenterology and Hepatology (Australia)
Volumn 11, Issue 11, 1996, Pages 1012-1015
Agranulocytosis induced by interferon-α therapy for chronic hepatitis C
Author keywords

Agranulocytosis; Chronic hepatitis C; G CSF; Interferon
Indexed keywords

ALPHA INTERFERON; ALPHA2B INTERFERON; ANTIVIRUS AGENT;
EID: 0030279840     PISSN: 08159319     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1746.1996.tb00023.x     Document Type: Article
Times cited : (12)
References (8)
  • 1
    • 0022590832 scopus 로고
    • Clinical toxicity of interferons in cancer patients; a review
    • Quesada JR, Talpaz M, Rios A et al. Clinical toxicity of interferons in cancer patients; A review. J. Clin. Oncol. 1986; 4: 234-43.
    • (1986) J. Clin. Oncol. , vol.4 , pp. 234-243
    • Quesada, J.R.1    Talpaz, M.2    Rios, A.3
  • 2
    • 0021167503 scopus 로고
    • Changes in the bone marrow of cancer patients treated with recombinant interferon alpha-2
    • Emstoff MS, Kirkwood JM. Changes in the bone marrow of cancer patients treated with recombinant interferon alpha-2. Am. J. Med. 1984; 76: 593-6.
    • (1984) Am. J. Med. , vol.76 , pp. 593-596
    • Emstoff, M.S.1    Kirkwood, J.M.2
  • 3
    • 0026757016 scopus 로고
    • Phase II evaluation of fluorouracil and recombinant α-2a-Interferon in previously untreated patients with pancreatic adenocarcinoma
    • Pazur R, Ajani JJ, Abbruzzese JL et al. Phase II evaluation of fluorouracil and recombinant α-2a-Interferon in previously untreated patients with pancreatic adenocarcinoma. Cancer 1992; 70: 2073-6.
    • (1992) Cancer , vol.70 , pp. 2073-2076
    • Pazur, R.1    Ajani, J.J.2    Abbruzzese, J.L.3
  • 4
    • 0029128055 scopus 로고
    • Granulocytopenia after combined therapy with interferon and angiotensin-converting enzyme inhibitors; Evidence for a synergistic hematologic toxicity
    • Casato M, Pucillo LP, Leoni M et al. Granulocytopenia after combined therapy with interferon and angiotensin-converting enzyme inhibitors; Evidence for a synergistic hematologic toxicity. Am. J. Med. 1995; 99: 386-91.
    • (1995) Am. J. Med. , vol.99 , pp. 386-391
    • Casato, M.1    Pucillo, L.P.2    Leoni, M.3
  • 5
    • 0022549329 scopus 로고
    • Recombinant human granulocyte colony-stimulating factor: Effects on normal and leukemic myeloid cells
    • Souza LM, Boone TC, Gabrilove J et al. Recombinant human granulocyte colony-stimulating factor: Effects on normal and leukemic myeloid cells. Science 1986; 232: 61-5.
    • (1986) Science , vol.232 , pp. 61-65
    • Souza, L.M.1    Boone, T.C.2    Gabrilove, J.3
  • 6
    • 0024374760 scopus 로고
    • Treatment of drug-induced agranulocytosis with granulocyte-colony stimulat-ing factor
    • Muroi K, Ito M, Sasaki R et al. Treatment of drug-induced agranulocytosis with granulocyte-colony stimulat-ing factor. Lancet 1989; 335: 55.
    • (1989) Lancet , vol.335 , pp. 55
    • Muroi, K.1    Ito, M.2    Sasaki, R.3
  • 7
    • 0019470317 scopus 로고
    • Human leukocyte interferon preparation-mediated block of granulo-poietic differentiation in vitro
    • Spitzer VD, Zander A, Gutterman JU et al. Human leukocyte interferon preparation-mediated block of granulo-poietic differentiation in vitro. Exp. Hematol. 1981; 9: 63-6.
    • (1981) Exp. Hematol. , vol.9 , pp. 63-66
    • Spitzer, V.D.1    Zander, A.2    Gutterman, J.U.3
  • 8
    • 0028147690 scopus 로고
    • Einsatz von zytokinen in der padiatrie
    • Gadner H. Einsatz von zytokinen in der padiatrie. Klin. Padiatr. 1994; 206: 2-11.
    • (1994) Klin. Padiatr. , vol.206 , pp. 2-11
    • Gadner, H.1

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.